Advancing the Science of Immuno-Oncology: BMS India Introduces RELOPDUO™ for Metastatic Melanoma
Mumbai, India – Bristol Myers Squibb (BMS) announced the launch of RELOPDUO™ in India following an approval from the Central Drugs ...
Mumbai, India – Bristol Myers Squibb (BMS) announced the launch of RELOPDUO™ in India following an approval from the Central Drugs ...
© 2016 – 2025 TechZone Print Media | All Rights Reserved